Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1996-2-8
|
pubmed:abstractText |
Monoamine oxidases are important in the regulation of monoaminergic neurotransmission. An increase in monoamine oxidase B (MAO B) has been observed in some neurodegenerative diseases, and therefore quantification of cerebral MAO B activity by SPECT would be useful for the diagnosis and therapeutic follow-up of these disorders. We have developed an iodinated derivative of pargyline, a selective inhibitor of MAO B, in order to explore this enzyme by SPECT. Stable bromo and iodo derivatives of pargyline were synthesized and chemically characterized. The radioiodinated ligand [125I]-2-iodopargyline was obtained with high specific activity from the bromo precursor by nucleophilic exchange. Affinity and selectivity of 2-iodopargyline were tested in vitro. Biodistribution study of [125I]-2-iodopargyline was performed in rats. Radioiodinated ligand were obtained in a no-carrier-added form. 2-iodopargyline has a higher in vitro affinity for MAO B than pargyline. However, the in vitro selectivity for MAO B was better for pargyline than for 2-iodopargyline. Ex vivo autoradiographic studies and in vivo saturation studies with selective inhibitors of MAO showed that the cerebral biodistribution of [125I]-2-iodopargyline in the rat is consistent with high level binding to MAO B sites in the pineal gland and in the thalamus. In conclusion, 2-iodopargyline preferentially binds in vivo to MAO B sites with high affinity. However, its selectivity for MAO B in rats is not very high, whereas this ligand binds to a lesser extent to MAO A. It will be then of great value to evaluate the specificity of 2-iodopargyline in humans. This new ligand labeled with 123I should therefore be a suitable tool for SPECT exploration of MAO B in the human brain.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0969-8051
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
727-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8535333-Animals,
pubmed-meshheading:8535333-Autoradiography,
pubmed-meshheading:8535333-Brain,
pubmed-meshheading:8535333-Humans,
pubmed-meshheading:8535333-Iodine Radioisotopes,
pubmed-meshheading:8535333-Isotope Labeling,
pubmed-meshheading:8535333-Male,
pubmed-meshheading:8535333-Monoamine Oxidase,
pubmed-meshheading:8535333-Organ Specificity,
pubmed-meshheading:8535333-Pargyline,
pubmed-meshheading:8535333-Pineal Gland,
pubmed-meshheading:8535333-Rats,
pubmed-meshheading:8535333-Rats, Wistar,
pubmed-meshheading:8535333-Thalamus,
pubmed-meshheading:8535333-Tissue Distribution,
pubmed-meshheading:8535333-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
1995
|
pubmed:articleTitle |
Iododerivative of pargyline: a potential tracer for the exploration of monoamine oxidase sites by SPECT.
|
pubmed:affiliation |
Laboratoire de Biophysique Médicale et Pharmaceutique, INSERM U316, Tours-France.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|